In silico evaluation and exploration of antibiotic tuberculosis treatment regimens
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In silico evaluation and exploration of antibiotic tuberculosis treatment regimens
Authors
Keywords
Computational model, Pharmacokinetic/Pharmacodynamic, Isoniazid, Rifampin, Tissue distribution
Journal
BMC Systems Biology
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-14
DOI
10.1186/s12918-015-0221-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
- (2015) Martin J. Boeree et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Immunology studies in non-human primate models of tuberculosis
- (2015) JoAnne L. Flynn et al. IMMUNOLOGICAL REVIEWS
- A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
- (2015) Elsje Pienaar et al. JOURNAL OF THEORETICAL BIOLOGY
- Shortening treatment of tuberculosis: lessons from fluoroquinolone trials
- (2015) Camus Nimmo et al. LANCET INFECTIOUS DISEASES
- Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery
- (2015) Meenal Datta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Strategies for Efficient Numerical Implementation of Hybrid Multi-scale Agent-Based Models to Describe Biological Systems
- (2014) Nicholas A. Cilfone et al. Cellular and Molecular Bioengineering
- DFT Based QSAR/QSPR Models in the Development of Novel Anti-tuberculosis Drugs Targeting Mycobacterium tuberculosis
- (2014) Sanchaita Rajkhowa et al. CURRENT PHARMACEUTICAL DESIGN
- QSAR Based Design of New Antitubercular Compounds: Improved Isoniazid Derivatives Against Multidrug-Resistant TB
- (2014) Filomena Martins et al. CURRENT PHARMACEUTICAL DESIGN
- Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation duringMycobacterium tuberculosisInfection
- (2014) Nicholas A. Cilfone et al. JOURNAL OF IMMUNOLOGY
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells
- (2014) Véronique Dartois NATURE REVIEWS MICROBIOLOGY
- Shortening Treatment for Tuberculosis — Back to Basics
- (2014) Digby F. Warner et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
- (2014) Corinne S. Merle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
- (2014) Amina Jindani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens
- (2013) Philana Ling Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A medicinal chemists’ guide to the unique difficulties of lead optimization for tuberculosis
- (2013) Véronique Dartois et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Update—Pathogens of concern
- (2013) Robin B. McFee DM DISEASE-A-MONTH
- Advances in the development of new tuberculosis drugs and treatment regimens
- (2013) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Multi-Scale Modeling Predicts a Balance of Tumor Necrosis Factor-α and Interleukin-10 Controls the Granuloma Environment during Mycobacterium tuberculosis Infection
- (2013) Nicholas A. Cilfone et al. PLoS One
- Controlled-release approaches towards the chemotherapy of tuberculosis
- (2012) Bullo Saifullah et al. International Journal of Nanomedicine
- Differential Risk of Tuberculosis Reactivation among Anti-TNF Therapies Is Due to Drug Binding Kinetics and Permeability
- (2012) M. Fallahi-Sichani et al. JOURNAL OF IMMUNOLOGY
- Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial
- (2012) Rovina Ruslami et al. LANCET INFECTIOUS DISEASES
- Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
- (2012) P. L. Lin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
- (2011) Maria C. Kjellsson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- High-dose rifampicin: how do we proceed? [Correspondence]
- (2011) M. J. Boeree et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Multiscale Computational Modeling Reveals a Critical Role for TNF- Receptor 1 Dynamics in Tuberculosis Granuloma Formation
- (2011) M. Fallahi-Sichani et al. JOURNAL OF IMMUNOLOGY
- Drug Forgiveness and Interpatient Pharmacokinetic Variability in Tuberculosis
- (2011) Véronique Dartois JOURNAL OF INFECTIOUS DISEASES
- Multidrug-Resistant Tuberculosis Not Due to Noncompliance but to Between-Patient Pharmacokinetic Variability
- (2011) Shashikant Srivastava et al. JOURNAL OF INFECTIOUS DISEASES
- Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis
- (2010) J. E. M. de Steenwinkel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Treatment of tuberculosis and optimal dosing schedules
- (2010) K. C. Chang et al. THORAX
- Population Modeling and Monte Carlo Simulation Study of the Pharmacokinetics and Antituberculosis Pharmacodynamics of Rifampin in Lungs
- (2009) S. Goutelle et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Advances in Immunotherapy for Tuberculosis Treatment
- (2009) Gavin J. Churchyard et al. CLINICS IN CHEST MEDICINE
- Quantitative Comparison of Active and Latent Tuberculosis in the Cynomolgus Macaque Model
- (2009) P. L. Lin et al. INFECTION AND IMMUNITY
- Resistant mutants of Mycobacterium tuberculosis selected in vitro do not reflect the in vivo mechanism of isoniazid resistance
- (2009) Indra L. Bergval et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synergy between Individual TNF-Dependent Functions Determines Granuloma Performance for Controlling Mycobacterium tuberculosis Infection
- (2009) J. C. J. Ray et al. JOURNAL OF IMMUNOLOGY
- Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
- (2009) Dick Menzies et al. PLOS MEDICINE
- Association of slow N-acetyltransferase 2 profile and anti-TB drug-induced hepatotoxicity in patients from Southern Brazil
- (2008) L. G. Possuelo et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started